LEADER 01024nam0-22003611i-450- 001 990004332010403321 005 20150930152954.0 010 $a3-402-08536-4 035 $a000433201 035 $aFED01000433201 035 $a(Aleph)000433201FED01 035 $a000433201 100 $a19990604d1991----km-y0itay50------ba 101 0 $ager 105 $aaf------00--- 200 1 $aTesserae$efestschrift für Josef Engemann 210 $aMünster$cAschendorffsche Verlagsbuchhhandlung$d1991 215 $aX, 419 p., 64 tav.$cill.$d28 cm 225 1 $aJahrbuch fur Antike und Christentum. Erganzungsband$v18 610 0 $aArte cristiana$aArchitettura 676 $a726.3 676 $a722 676 $a246 676 $a938 702 1$aEngemann,$bJosef 702 1$aDassmann,$bErnst$f<1931-> 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990004332010403321 952 $a722 ENG 1$bBibl. 13350$fFLFBC 952 $a722 ENG 1 BIS$bBibl. 13342$fFLFBC 959 $aFLFBC 997 $aUNINA LEADER 02931nam 2200625z- 450 001 9910557290903321 005 20210501 035 $a(CKB)5400000000041130 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69157 035 $a(oapen)doab69157 035 $a(EXLCZ)995400000000041130 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aQuantum Communication-Celebrating the Silver Jubilee of Teleportation 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (106 p.) 311 08$a3-03943-026-2 311 08$a3-03943-027-0 330 $aTo celebrate the 25th anniversary of the seminal 1993 quantum teleportation paper, we are pleased to present research works, reviews, and stories about quantum communication, quantum entanglement, and quantum teleportation: (1) How was quantum teleportation invented? (2) Which teleportation experiments were performed at the Sapienza University in Rome? (3) Can we use joint measurements to generate nonclassical correlations? (4) How is classical sampling related to quantum entanglement? (5) How is classical communication related to a special quantum ensemble? (6) How can simplifying a quantum key distribution protocol make it insecure? (7) Can we teleport a two-qubit quantum state using a nonsymmetric channel? This book includes submissions by some of the most prominent quantum teleportation contributors, including Gilles Brassard, Francesco De Martini, Nicolas Gisin, and William K. Wootters, as well as additional researchers, all presenting their up-to-date insights regarding quantum communication. 606 $aResearch & information: general$2bicssc 610 $aaccessible information 610 $aattack 610 $aclassical simulation of entanglement 610 $acommunication complexity 610 $aentanglement 610 $aentropy 610 $aexact sampling 610 $aGAP measure 610 $anonlocality 610 $aphotonics 610 $aquantum channel 610 $aquantum communication 610 $aquantum entanglement 610 $aquantum information 610 $aquantum key distribution 610 $aquantum measurements 610 $aquantum teleportation 610 $aquantum theory 610 $arandom bit model 610 $asecurity 610 $asemiquantum key distribution 610 $asubentropy 615 7$aResearch & information: general 700 $aLiss$b Rotem$4edt$01329327 702 $aMor$b Tal$4edt 702 $aLiss$b Rotem$4oth 702 $aMor$b Tal$4oth 906 $aBOOK 912 $a9910557290903321 996 $aQuantum Communication-Celebrating the Silver Jubilee of Teleportation$93039433 997 $aUNINA LEADER 06258nam 22007575 450 001 9910765485003321 005 20251008143546.0 010 $a3-031-39928-5 024 7 $a10.1007/978-3-031-39928-2 035 $a(MiAaPQ)EBC30954472 035 $a(Au-PeEL)EBL30954472 035 $a(DE-He213)978-3-031-39928-2 035 $a(CKB)28893368800041 035 $a(EXLCZ)9928893368800041 100 $a20231118d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiology of Women?s Heart Health /$fedited by Lorrie Kirshenbaum, Inna Rabinovich-Nikitin 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023. 215 $a1 online resource (0 pages) 225 1 $aAdvances in Biochemistry in Health and Disease,$x2512-2150 ;$v26 311 08$aPrint version: Kirshenbaum, Lorrie Biology of Women's Heart Health Cham : Springer International Publishing AG,c2024 9783031399275 327 $aAttenuation of Bnip3 Mediated Doxorubicin-Induced Cell Death in Cardiac Myocytes -- Sex Dependent Regulation of Circadian Rhythms in Health and Disease -- Circadian Pharmacological Approach to Treat Myocardial Infarct -- GPER Function as a Determinant of the Progression of Atherosclerotic Disease in Women -- Novel Therapeutic Approach to Treat Cardiac-Rheumatology in Females -- Correlation between Sex, Immigration Status, Ethnicity, and Long-term Outcomes of Ischemic Stroke -- Risk Assessment and Predictive Modelling for The Heart-Brain Interface in Women -- Insomnia Interventions for Female Cardiac Patients -- Aortic Stenosis Progression, Cardiac Damage, and Survival: Comparison Between Men and Women -- Treatment and Management of Valvular Heart Disease and Cost-Effectiveness Analysis -- Association of Mortality and Acute Aortic Events with Ascending Aortic Aneurysm -- Improving Diagnosis and Treatment for Patients Who Suffer Spontaneous Coronary Artery Dissection (SCAD) -- Preeclampsia andFuture Cardiovascular Health -- Cardiovascular Disease in Women with a History of Pregnancy Complications -- Hormone Replacement Treatment for Cardiovascular Disease -- Cardiovascular Mortality Following Early-Stage Breast Cancer -- Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease in Women -- Sex Differences in Cardiac Rehabilitation Enrollment -- Promoting Exercise and Physical Activity in Female Patients with Heart Disease -- Sex and Gender Differences in the Diagnosis, Treatment, and Outcomes of Coronary Artery Disease -- Sex Differences in Arterial Aging and its Implications on Cardiovascular Diseases -- Impact of a Novel Community-Based Lifestyle Intervention Program on Type 2 Diabetes and Cardiovascular Risk -- Clinical Outcomes Related to Heart Failure and Pulmonary Hypertension -- Examination of Health-Related Quality of Life in Women with Coronary Artery Disease -- The Risks and Benefits of Implantable Cardioverter-Defibrillator Generator Replacement -- The Effects and Roles of Estrogen in Managing Hypertension in Menopausal Women -- The Effects of Menopausal Hormone Therapy on the Vascular System -- Influence of Sex Differences in Non-Obstructive Coronary Artery Disease -- Diet1 and Resistance to High Cholesterol Levels and Cardiovascular Disease -- Interventions to Improve Clinical Outcomes Following Hospitalization for Heart Failure -- Sex-Dependent Cardioprotective Effects of the Phytoestrogen Resveratrol -- Blood Pressure Across a Woman's Life Cycle -- Women?s Fitness Levels and Heart Rate Response to Exercise -- Supervised Exercise Therapy Through Cardiac Rehabilitation following Peripheral Arterial Disease -- Sex Differences in ANT2-Mediated ATP Import into Mitochondria for Protection Against Hypoxia Lethal Injury. 330 $aCardiovascular disease (CVD) is the leading cause of morbidity and mortality in women and men worldwide and represents a major financial burden to world health care systems. Importantly, CVD has eclipsed cancer as the leading cause of death for women globally. Through advancements in research and clinical testing, the symptoms and risk factors for CVD have been well established for men, but not for women. Consequently, there is an immediate need for new innovative research that will bridge this gap and allow for improved early diagnosis and treatment of CVD in women. This book will serve as a guide for health care providers to better understand the physiological, biochemical, and genetic differences in heart disease in women with the goal of providing improved education, awareness and treatment of cardiovascular disease in women. The book will cover topics such as: sex dependent clinical outcomes of cardiovascular disease, cardiac protection by estrogen, cardiac health during menopause, cardiac rehabilitation programs, fitness and exercise, cardio-oncology, shift work and the CVD risk, and pregnancy related CVD. 410 0$aAdvances in Biochemistry in Health and Disease,$x2512-2150 ;$v26 606 $aCardiovascular system 606 $aPhysiology 606 $aCardiology 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aMedical sciences 606 $aHealth 606 $aSex 606 $aCardiovascular Physiology 606 $aCardiology 606 $aBiomedical Research 606 $aHealth Sciences 606 $aGender and Health 615 0$aCardiovascular system. 615 0$aPhysiology. 615 0$aCardiology. 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 0$aMedical sciences. 615 0$aHealth. 615 0$aSex. 615 14$aCardiovascular Physiology. 615 24$aCardiology. 615 24$aBiomedical Research. 615 24$aHealth Sciences. 615 24$aGender and Health. 676 $a616.10082 676 $a616.10082 700 $aKirshenbaum$b Lorrie$01448910 701 $aRabinovich-Nikitin$b Inna$01448911 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910765485003321 996 $aBiology of Women?s Heart Health$93644919 997 $aUNINA